Treatment of Pseudomonas Osteomyelitis

Introduction to Treatment

• The American College of Physicians recommends switching to ciprofloxacin 750 mg PO twice daily after initial clinical improvement to complete a total 6-week course for Pseudomonas osteomyelitis treatment 1, 2
• The Infectious Diseases Society of America suggests that levofloxacin 750 mg PO once daily is an alternative if ciprofloxacin resistance is documented 1

Surgical Considerations

• The American Academy of Orthopaedic Surgeons states that surgical debridement is the cornerstone of osteomyelitis therapy and must be performed for substantial bone necrosis or exposed bone 1, 2
• The Society for Healthcare Epidemiology of America recommends that if adequate surgical debridement with negative bone margins is achieved, antibiotic duration can be shortened to 2-4 weeks total 1, 2

Duration of Therapy

• The International Society for the Study of Infection recommends 6 weeks of antibiotics for osteomyelitis without surgical debridement or with incomplete resection 1, 3
• The American College of Physicians suggests 2-4 weeks of antibiotics after complete surgical resection with negative bone margins 1, 2

Monitoring and Follow-Up

• The Infectious Diseases Society of America recommends following ESR and CRP levels weekly to guide response to therapy 1, 2
• The American Academy of Physical Medicine and Rehabilitation states that assessing clinical response at 6 months after completing antibiotic therapy is necessary to confirm remission 1, 4

Special Considerations

• The American Diabetes Association suggests that optimal wound care with debridement and off-loading is crucial in addition to antibiotics for diabetic foot osteomyelitis 1, 2
• The Society for Vascular Surgery recommends that patients with severe peripheral artery disease may require extending antibiotic duration up to 3-4 weeks beyond standard recommendations 4

Common Pitfalls

• The American College of Physicians advises against empirically targeting Pseudomonas in temperate climates unless it has been isolated from cultures within the previous few weeks 4
• The Infectious Diseases Society of America recommends against continuing gentamicin beyond 2-4 weeks due to cumulative toxicity 1, 2
• The American Academy of Orthopaedic Surgeons suggests against using oral beta-lactams for transition therapy due to poor bioavailability 1